A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease
about
Antiplatelet resistance in strokeThe pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19Aspirin resistance: current status and role of tailored therapySynthetic polyphosphate inhibits endogenous coagulation and platelet aggregation in vitroInhibition of platelet activation could decrease thrombotic events in hemodialysis PF4/H antibody-positive patients.Selective and rapid monitoring of dual platelet inhibition by aspirin and P2Y12 antagonists by using multiple electrode aggregometry.Multi-parameter assessment of platelet inhibition and its stability during aspirin and clopidogrel therapyMicrofluidic assay of platelet deposition on collagen by perfusion of whole blood from healthy individuals taking aspirinEffect of opium addiction on aspirin resistance in stable angina pectoris.Increased platelet expression of glycoprotein IIIa following aspirin treatment in aspirin-resistant but not aspirin-sensitive subjects.Clinical determinants of aspirin resistance in diabetesClinical importance of aspirin and clopidogrel resistanceThe role of point-of-care assessment of platelet function in predicting postoperative bleeding and transfusion requirements after coronary artery bypass graftingEffect of glucose or fat challenge on aspirin resistance in diabetes.Monitoring the effectiveness of antiplatelet therapy: opportunities and limitations.Effect of gender difference on platelet reactivity.Aspirin resistance in off-pump coronary artery bypass grafting.Blood biomarkers of ischemic stroke.Comparison of Aggregometry with Flow Cytometry for the Assessment of Agonists´-Induced Platelet Reactivity in Patients on Dual Antiplatelet Therapy.Bleeding tendency in dual antiplatelet therapy with aspirin/clopidogrel: rescue of the template bleeding time in a single-center prospective study.Antiplatelet resistance and thromboembolic complications in neurointerventional procedures.P2RY1 and P2RY12 polymorphisms and on-aspirin platelet reactivity in patients with coronary artery disease.Assessment of platelet function in patients with stroke using multiple electrode platelet aggregometry: a prospective observational study.Inflammation and circulating endothelial progenitor cells in patients with coronary artery disease and residual platelet reactivityUrinary metabolites of prostanoids and risk of recurrent colorectal adenomas in the Aspirin/Folate Polyp Prevention Study (AFPPS).High On-Aspirin Platelet Reactivity and Clinical Outcome in Patients With Stable Coronary Artery Disease: Results From ASCET (Aspirin Nonresponsiveness and Clopidogrel Endpoint Trial)Correlation between the CYP2C19 phenotype status and the results of three different platelet function tests in cardiovascular disease patients receiving antiplatelet therapy: an emphasis on newly introduced platelet function analyzer-200 P2Y test.Expression of the PlA2 allele of glycoprotein IIIa and its impact on platelet function.Protocol for a systematic review of the diagnostic and prognostic utility of tests currently available for the detection of aspirin resistance in patients with established cardiovascular or cerebrovascular diseasePrevalence of and risk factors for aspirin resistance in elderly patients with coronary artery diseaseAspirin resistance: biological and clinical implications.Pharmacogenetics of aspirin resistance: a comprehensive systematic review.The use of the VerifyNow system to monitor antiplatelet therapy: a review of the current evidence.Monitoring oral antiplatelet therapy: is it justified?Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the WoMicrofluidic thrombosis under multiple shear rates and antiplatelet therapy dosesUpdate on oral antiplatelet therapy: principles, problems and promises.Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention.A Pilot Study on the Effect of Angiotensin Receptor Blockers on Platelet Aggregation in Hypertensive Patients- A Prospective Observational Study.Aspirin resistance in patients with type II diabetes mellitus.
P2860
Q22305927-239273A6-14A8-49EE-827A-4DCC7870254CQ26801867-7F7BFCC7-A77D-4A6F-A1C3-F82D417957E8Q26851367-4165ED3D-233D-4414-9EC0-506A94D91CE2Q28559769-0656F262-0911-4DA1-8DCD-C2FF1204A7ADQ33414182-8AB55C44-758E-4F87-A52E-8D51ED2E1605Q33881728-526AD7B2-E45D-4F48-A769-67C73A7D6C5AQ33898876-3E4B1ED7-BAE9-496F-99F0-59DA15333696Q33992761-EED4650C-B4E2-44C4-BC0A-D2305FB78744Q34063900-F7A00381-5337-4965-88F0-95A4D99DDE4AQ34065288-112DFE3A-555E-4B86-AAEA-AAF1DBA66EDAQ34234687-1D67D8AB-7E58-41C0-B772-47F85D1609FEQ34390050-2B3315F9-9260-4CBF-B4BF-0AFA77C55F65Q34457019-9BE909FA-D55B-4FAC-A75D-463C2678F97CQ34557275-948491DA-20EA-465F-8B93-ECED3024CD11Q35373683-84E3C49A-FD0C-4875-857F-0A94E457A608Q35473568-A72251E3-F6A4-463B-8197-109DB8EFBC33Q35619792-6640E417-93E9-43F8-8E1A-4918206D0776Q35648087-1B0AF6EC-B3A2-4EAB-B694-E61032CFE6DAQ35658513-6330538E-D13D-4BBF-B243-4826D1010C5CQ35707491-B3C1DE8D-D8DA-48C6-ABFB-86A0BE38EA4DQ35750126-DE24DE43-2DAD-4749-A5A7-B2777EE5A45EQ36164883-BC7C0934-8F0A-4E42-9259-BB34CA12240BQ36219096-57FC0977-4148-47BB-A253-59BCE7B4CF7DQ36223037-32D5AEFB-44BF-4B61-98E2-9F6E6D98A736Q36248969-42A9DE76-07FF-41EC-9C25-097EF3D91BB1Q36366209-6DF2209C-17F3-4A11-8243-7BC1F3256480Q36419684-6CD7E98B-01AB-4712-BB6E-C20FD45BADC7Q36524428-64454EE4-DB50-40B6-8522-DD8439D9AFD4Q36693620-9E53D542-8391-4847-AC8D-DB903A64A78DQ36769860-7056764A-4090-4800-90A9-344CABD27CF7Q37089560-C64F3502-1E2C-4D86-AE42-3C23D90DB5D2Q37145122-CF5A8175-887E-49D3-9789-AB6ABFF27137Q37315628-02E96FF4-4EC1-47AF-B3A4-8F0A233FCC3EQ37362783-D2339131-DFBC-4030-99CB-E8C9C78C00F7Q37378896-FEF6594D-203B-4B03-8934-130494EBD480Q37431386-5B0BA535-8B1E-4F0B-BA3C-1DB14796752BQ37486605-087BAB7F-1332-4DD5-98D5-B9D4945616D4Q37497555-FD4F340E-CC3C-4924-AC33-531126E5696FQ37543016-7A7F1A86-2005-42CA-8FE6-0761C108FC3DQ37564161-B41FD1FA-ABB1-4DED-898F-9CB5C4938F14
P2860
A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
A comparison of six major plat ...... stable coronary artery disease
@ast
A comparison of six major plat ...... stable coronary artery disease
@en
A comparison of six major plat ...... stable coronary artery disease
@nl
type
label
A comparison of six major plat ...... stable coronary artery disease
@ast
A comparison of six major plat ...... stable coronary artery disease
@en
A comparison of six major plat ...... stable coronary artery disease
@nl
prefLabel
A comparison of six major plat ...... stable coronary artery disease
@ast
A comparison of six major plat ...... stable coronary artery disease
@en
A comparison of six major plat ...... stable coronary artery disease
@nl
P2093
P356
P1476
A comparison of six major plat ...... stable coronary artery disease
@en
P2093
Chantal Pharand
Donald A Palisaitis
Erick Schampaert
Jacques Turgeon
Jean G Diodati
Marie Lordkipanidzé
P304
P356
10.1093/EURHEARTJ/EHM226
P407
P577
2007-07-01T00:00:00Z